Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

walgreens - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

the kroger co. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

safeway, inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

meijer, inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

stryke club, inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

meijer distribution inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

cvs pharmacy, inc - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

safeway, inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

topco associates - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - acne treatment - for the treatment of acne

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

bryant ranch prepack - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - adapalene and benzoyl peroxide gel, 0.1%/2.5% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. none pregnancy category c. there are no well-controlled trials in pregnant women treated with adapalene and benzoyl peroxide gel, 0.1%/2.5%. animal reproduction studies have not been conducted with the combination gel or benzoyl peroxide. furthermore, such studies are not always predictive of human response; therefore, adapalene and benzoyl peroxide gel, 0.1%/2.5% should be used during pregnancy only if the potential benefit justifies the risk to the fetus. no teratogenic effects were observed in rats treated with oral doses of 0.15 to 5.0 mg adapalene/kg/day, up to 25 times (mg/m2 /day) the maximum recommended human dose (mrhd) of 2 grams of adapalene and benzoyl peroxide gel, 0.1%/2.5%. however, teratogenic changes were observed in rats and rabbits when treated with oral doses of ≥ 25 mg adapalene/kg/day representing 123 and 246 times mrhd, respectively. findings included cleft palate, microphthalmia, encephalocele and skeletal abnormalities in rats; and umbilical hernia, exophthalmos and kidney and skeletal abnormalities in rabbits. dermal teratology studies conducted in rats and rabbits at doses of 0.6-6.0 mg adapalene/kg/day [25-59 times (mg/m2 ) the mrhd] exhibited no fetotoxicity and only minimal increases in supernumerary ribs in both species and delayed ossification in rabbits. it is not known whether adapalene or benzoyl peroxide is excreted in human milk following use of adapalene and benzoyl peroxide gel, 0.1%/2.5%. because many drugs are excreted in human milk, caution should be exercised when adapalene and benzoyl peroxide gel, 0.1%/2.5% is administered to a nursing woman. safety and effectiveness of adapalene and benzoyl peroxide gel, 0.1%/2.5% in pediatric patients under the age of 9 have not been established. clinical studies of adapalene and benzoyl peroxide gel, 0.1%/2.5% did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.